# VEOZAH

NDC: 0469-2760
Generic name: fezolinetant
Labeler / Manufacturer: Astellas Pharma US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230512

FDA application: NDA216578

## Active ingredients

- FEZOLINETANT: 45 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0469-2760"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0469-2760
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cae9f798-24f9-4580-a4fc-e6c710cbda3c